Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Versartis commences phase Ia trial of VRS-859 in type 2 diabetes

June 28, 2010

GSK claims calcium-sensing CaS receptor ligands

June 28, 2010

RAD-1901 is efficacious in phase IIa trial in postmenopausal women

June 28, 2010

Novo Nordisk restarts phase III development of liraglutide for obesity

June 25, 2010

Takeda announces U.S. launch of ACTOplus met XR

June 25, 2010

OMJPI and Diamyd join to develop diabetes therapy rhGAD65

June 25, 2010

VIA Pharmaceuticals discloses new DGAT inhibitors

June 25, 2010

Kowa Pharmaceuticals America and Lilly launch Livalo in the U.S.

June 23, 2010

Zydus receives permission for phase I trial of ZYOG-1 in India

June 22, 2010

FDA recommends approval of emergency contraceptive ulipristal

June 22, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 3, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...